ArticleFrontiers in oncology2021

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.

Alessio Biagioni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.